Tag: #MArket

The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research London Roots Analysis has announced... Read More

To order this detailed 250+ page report, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html Key Inclusions  A detailed assessment of the current market landscape of companies offering drug repurposing services based on several relevant... Read More

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities... Read More

Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon... Read More

To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html Key Inclusions  A detailed assessment of the overall landscape of companies with capabilities for... Read More

Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon... Read More

Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications London Roots Analysis has announced the addition of “Vascular Disrupting Agents Market,... Read More

To order this detailed 320+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/neoantigen-targeted-therapies-market-2019-2030/257.html Key Inclusions  A detailed assessment of the current market landscape, providing information on drug developer(s), phase of development... Read More

Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications London Roots Analysis has announced the addition of “Vascular Disrupting Agents Market,... Read More

The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies with the capabilities to manufacture viral and non-viral... Read More